Patent Application
20100249753
The present invention relates generally to the field of syringe-type medical device instrumentation and methods, and more specifically to a medical device containment, mixing and ejection system for the preparation and delivery of wetted particulate materials, and its method of use. Such a system may be used, for example, for the preparation and application of particulate synthetic bone graft devices.
In medicine, there is often a need for the application of a graft material to a bone defect that may have originated from disease, surgery, or traumatic injury. Such bone graft materials may consist of either organic tissue or synthetic materials. Organic tissue may include human bone tissue collected either from the patient or from a donor, either human (i.e. cadaveric) or animal sources.
Synthetic materials, those not involving human and/or animal tissues, can be of several different forms. Some materials, such as metals and certain ceramics, are intended as bulk devices for permanent replacements to the original bone, supporting the applied loads and bone function. These, however, change the physiologic balance at the graft site and may impair or impeded healing of the graft site. Other materials, such as calcium sulfate ceramics, may be implanted as slurries or cements. These materials fill the graft site and harden, preventing repair of the defect due to their physical presence. While some of these materials are permanent, others are temporary and are absorbed. If this absorption is too rapid, such as with calcium sulfate ceramics, the material will be absorbed before new bone tissue can form and heal.
A third forth for synthetic graft materials consists of particulate devices. These devices, typically polymeric, glass, or ceramic in nature, consist of aggregations of discrete particles. The spaces between the particles permit defect healing by virtue of new bone tissue formation and ingrowth. One such particulate material, bioactive glass, has been demonstrated to directly stimulate the cells necessary for bone formation when in particulate form. As a preferred example, one specific bioactive glass composition, termed Bioglass®, has a composition of 21% silicon, 18% calcium, 18% sodium, 3% phosphorus, and 40% oxygen (by weight percent). This Bioglass material has been used clinically for over 15 years as a particulate bone graft device.
One of the drawbacks with particulate bone graft devices is their preparation. Most particulate materials are supplied in a cup or bottle, from which they are extracted, placed in a sterile basin or bowl, and mixed with an activating or wetting agent. Extensive manual manipulation of the material may be required to wet the entire device properly. Similarly, variations in device wetting may occur due to differing amounts of fluid being added with each device preparation. Another drawback with this method of mixing is that after mixing, the wetted material must be manually removed from the basin and placed in the graft site with a surgical instrument such as a rongeur or spatula. Frequently, this transfer can result in partial loss of graft material volume due either to the inability to extract all the material from the mixing basin or to actual dropping of the material during handling.
One method to modify the handling and preparation of particulate materials is via their packaging and delivery vehicle. Some particulate devices, after dispensing and mixing in the sterile basin with the appropriate wetting agent, can be loaded into a syringe and expressed into the desired graft site. However, the preparation of these materials is still performed in a basin, requiring additional handling to reload the material into the device syringe.
To address the material handling issues, some devices are packaged in a syringe delivery system. One bioactive glass particulate device is available in a syringe format, the syringe having a porous screen cap over the end. To prepare the device, the end of the syringe with the screen cap is placed in the desired wetting fluid. On pulling back the syringe plunger, the vacuum created draws fluid up through the cap and into the graft material. Such systems are taught by multiple patents, including U.S. Pat. Nos. 5,181,918 and 6,554,803. One drawback to such systems is that the entire volume of the syringe cannot be used to contain the desired particulate material; the length of the syringe barrel must be at least twice that of the volume of graft material contained, otherwise the syringe will not be able to draw up sufficient fluid to completely wet the device. Once the material is wetted, this excess air must either be removed or forced through the wetted graft material on expression. In the case of U.S. Pat. No. 5,181,918, a separate valve and piston arrangement is included to remove this entrapped air from behind the wetted material.
Another particulate bone graft device packaged in a syringe more completely wets the device material, but requires a cumbersome array of equipment to accomplish. Instead of filling the syringe with fluid from the open end, this device is wetted via attachment of a second fluid syringe to the plunger seal at the base of the device particulate syringe. The device is wetted by expressing the wetting fluid into the particulate through the plunger seal. The fluid syringe is removed and a second plunger shaft is attached to the syringe seal. The device is then expressed by pressing on the plunger shaft. Such a syringe device is, in part, taught by U.S. Pat. No. 4,551,135, which presents a syringe having a means to attach a second syringe to the plunger to aid in fluid administration and mixing.
Other syringe devices have been designed for use with particulate materials, but none fully address all the issues. U.S. Pat. No. 4,405,249 shows a vented mixing syringe with apertures in the piston to allow for gas escape. U.S. Pat. No. 6,592,251, shows a mixing apparatus that utilizes two syringes.
To address issues raised by prior devices, a vented particulate mixing syringe device according to the present invention substantially departs from the conventional concepts and designs of the prior art, and in so doing, provides a device developed primarily for use as a mixing system for particulate bone graft materials, resulting in improved device preparation and delivery for the healing of bone defects.
In view of the foregoing disadvantages inherent with the known methods of bone graft device preparation and delivery present in the prior art, the present invention provides a new containment, mixing and delivery system for bone graft materials that improves device handling and can be readily applied to particulate bone graft materials to enhance material bone defect healing.
The general purpose of the present invention, which will be described subsequently in greater detail, is to provide a new containment mixing and delivery method and system for particulate bone graft materials that has many advantages over methods mentioned heretofore and many novel features that result in a new bone graft delivery device which is not anticipated, rendered obvious, suggested, or implied by any of the prior are bone graft materials, either alone or in any combination thereof.
To attain this, the present invention generally comprises an open-bore syringe, having a plunger, a barrel, a nozzle member mounted onto the distal open end of the barrel, a cap member mounted on nozzle to retain the device particulate, and a series of vents in the barrel of the syringe to permit release of entrapped air during instilling of a device wetting fluid. The wetting fluid is administered into the device through the nozzle member after removal of the cap member. The plunger is retracted or moved in the proximal direction during fluid instillation such that the vents are exposed, resulting in release of any entrapped air. The device is fully wetted when fluid begins to escape through the vent holes. Once the material has been wetted, the nozzle member is removed and the wetted particulate material expressed by depressing the plunger in the distal direction.
In this respect, before explaining at least one embodiment of the invention in detail, it is understood that the invention is not limited in its application to the details of application or the proportions thereof as set forth in the following description. The invention is capable of other similar embodiments. Also, it is to be understood that the phrasing and terminology employed herein are for the purpose of the description and should not be regarded as limiting.
The primary object of the present invention is to provide a device for the wetting of particulate materials and their subsequent delivery that will overcome the shortcomings of prior art devices.
An object of the present invention is to provide a syringe device for the wetting and preparation of particulate bone graft materials that will permit wetting of the material throughout the full volume of the graft material.
Another object of the invention is to provide a syringe device for the delivery of a prepared particulate bone graft material to the desired osseous graft site without further manual manipulation or handling of the prepared material.
Other objects and advantages of the present invention will become obvious to the reader and it is intended that these objects and advantages are within the scope of the present invention.
As described herein, the invention comprises a multi-component system and method of use that, when used with a suitable fluid, permits and promotes the preparation and delivery of a particulate material for use as a bone graft device. A preferred embodiment of the invention is a multi-component syringe system, the system being supplied either empty or pre-filled with a desired bone graft material. The multi-component syringe device 10 is further defined as comprising a syringe barrel 12, a syringe plunger 11, and a nozzle member 13. The components preferably are pre-assembled and pre-filled with the desired bone graft particulate material 21 needing mixing with a wetting solution prior to use. The system further comprises a wetting syringe 30 or similar device for expelling liquid that is structured so as to temporarily mate or connect with the distal end of the vented syringe 10 such that liquid may be forced from the wetting syringe 30 into the vented syringe 10.
The syringe barrel 12 primarily is cylindrical in form, having a forward or distal end and rearward or proximal end. Use of a translucent or clear material is preferred to permit visualization of the bone graft material content and the progress of fluid installation. The syringe plunger 11 is inserted through the proximal end of the syringe barrel 12. During use, the plunger 11 is pressed forward toward the distal or forward end of the barrel 12 in order to expel the wetted particulate material 21. The syringe plunger 11 is not capable of drawing sufficient liquid into the barrel 12 because of the presence of at least one vent hole 14.
The syringe plunger 11 generally is a straight plunger shaft—typically tubular, cylindrical or cross-shaped in cross-section. It may be composed of either a single material with suitable sealing properties, or' may be a two-component unit, consisting of a plunger shaft 16 and an attached polymeric or rubber plunger seal 15. The plunger 11 is designed to form a fluid-tight seal within the syringe barrel 12.
The nozzle member 13 generally is comprised of a polyethylene or polypropylene material. The nozzle member 13 is removably connected to the distal end of the syringe barrel 12. This removable connection is preferably obtained via a friction fit, although other means of connection such as screw threads also are encompassed within the invention. A cap member 17 may be mounted onto the nozzle member 13 to retain the particulate material 21. The nozzle member 13 may also feature a means 31 for the attachment of the wetting syringe 30 by which a wetting fluid is administered to the enclosed particulate material 21 at time of use.
Although other formats are possible within the scope of this invention, one preferred embodiment of the device is described herewith and illustrated in
In an alternate embodiment, the device comprises a polyethylene plunger 11 with a rubber seal 15, a clear polypropylene barrel 12, and a nozzle member 13. In this embodiment the barrel 12 is not vented through the wall. Instead, plunger vent holes 22 are placed in the end of the plunger shaft 16 and are closed with the rubber seal 15, which has a series of matching vent holes 23 that are rotatably offset from those in the plunger shaft 16, as shown in
In another alternative embodiment, the device consists of a plunger 11 and barrel 12 with a friction fit nozzle member 13. In this embodiment, the vent holes 22 are placed in the front or distal end of the plunger 11, the rear or proximal end being sealed with a rubber stopper 24, as shown in
As a functional overview, it is generally intended that the invention be supplied in a pre-assembled, pre-filled state. It is understood, however, that the device may be supplied empty, for filling in the surgical suite by any of a number of particulate bone graft devices available.
With respect to the above description, it is to be realized that the optimum relationship for the components of the invention, to include variations in component material, overall device size and volume, function and manner of mixing, operation, and use, are deemed readily apparent and obvious to one skilled in the art, and all equivalent relationships to those described in the specification are intended to be encompassed by the present invention.
Therefore, the foregoing is considered as illustrative only of the principles of the invention. Further, since modifications and changes will readily occur to those skilled in the art, it is not desired to limit the invention to the exact format and materials described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the claims of the invention.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 61/208,561, filed Feb. 25, 2009.
| Number | Date | Country | |
|---|---|---|---|
| 61208561 | Feb 2009 | US |
